Orbimed Capital Gp Vii Llc - Net Worth and Insider Trading

Orbimed Capital Gp Vii Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Orbimed Capital Gp Vii Llc owns 16 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , Pandion Therapeutics Inc (PAND) , and Fusion Pharmaceuticals Inc (FUSN) among others .

Click here to see the complete history of Orbimed Capital Gp Vii Llc’s form 4 insider trades.

Insider Ownership Summary of Orbimed Capital Gp Vii Llc

Ticker Comapny Transaction Date Type of Owner
ARQT Arcutis Biotherapeutics Inc 2020-02-03 director & 10 percent owner
PAND Pandion Therapeutics Inc 2020-07-16 10 percent owner
FUSN Fusion Pharmaceuticals Inc 2020-06-25 director
RPTX Repare Therapeutics Inc 2021-08-17 director
KROS Keros Therapeutics Inc 2020-04-07 director
IMRA Imara Inc 2020-03-11 director & 10 percent owner
PASG Passage Bio Inc 2022-01-11 10 percent owner
SRRA Sierra Oncology Inc 2019-11-22 director & 10 percent owner
THOR Synthorx Inc 2018-12-11 10 percent owner
THRX Theseus Pharmaceuticals Inc 2021-10-06 10 percent owner
KNTE Kinnate Biopharma Inc 2022-02-11 director
GLTO Galecto Inc 2020-10-28 director & 10 percent owner
JANX Janux Therapeutics Inc 2021-12-16 director
TERN Terns Pharmaceuticals Inc 2022-08-16 director & 10 percent owner
THRD Third Harmonic Bio Inc 2022-09-14 director & 10 percent owner
ELVN Enliven Therapeutics Inc 2020-03-11 director & 10 percent owner

Orbimed Capital Gp Vii Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Orbimed Capital Gp Vii Llc Ownership Network

Ownership Network List of Orbimed Capital Gp Vii Llc

No Data

Ownership Network Relation of Orbimed Capital Gp Vii Llc


Orbimed Capital Gp Vii Llc Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Orbimed Capital Gp Vii Llc is the director & 10 percent owner of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include SVP and Chief Business Officer Matthew Richard Moore , director & 10 percent owner Patrick J Heron , and director & President and CEO Todd Franklin Watanabe .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 30,155 shares made by Todd Franklin Watanabe , a net sale of 37,403 shares made by Howard G. Welgus , and a net sale of 10,594 shares made by Masaru Matsuda .

In summary, during the past 3 months, insiders sold 29,378 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 21,052 shares, with a net sale of 8,326 shares. During the past 18 months, 104,916 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 2,401 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Orbimed Capital Gp Vii Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Orbimed Capital Gp Vii Llc. You might contact Orbimed Capital Gp Vii Llc via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.

Discussions on Orbimed Capital Gp Vii Llc

No discussions yet.